Startseite Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance

  • Parvaneh Nikpour , Hajar Miranzadeh-Mahabadi , Modjtaba Emadi-Baygi und Roya Kelishadi EMAIL logo
Veröffentlicht/Copyright: 13. Mai 2014

Abstract

Objective: This study aims to evaluate the association of miR-33b/SREBP-1 rs8066560 with hyperglycemia and insulin resistance in Iranian children and adolescents.

Methods: This case-control study comprised 200 participants with 9–19 years of age, consisting of 100 MetS and 100 healthy controls. Anthropometric and biochemical parameters were measured, and the polymorphism was genotyped by TaqMan real-time PCR method.

Results: Logistic regression analysis of genotype distribution of rs8066560 did not show a significant association with MetS neither in boys (OR, 1.745; 95% CI, 0.695–4.382; p=0.236) nor in girls (OR, 1.075; 95% CI, 0.420–2.752; p=0.880). Participants with GG/AG genotypes had significant higher LDL-C levels than those with the AA genotype. No statistically significant difference was documented in fasting blood glucose and insulin levels between the three rs8066560 genotypes.

Conclusions: We found that rs8066560 variant on SREBP-1 and miR-33b genes is associated with LDL-C levels; however, it may not be an important determinant for the MetS, hyperglycemia, and insulin resistance in children and adolescents.


Corresponding author: Roya Kelishadi, MD, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran, Phone: +98 311 7923060, Fax: +98 311 6687898, E-mail:

Acknowledgments

This study was supported by a research grant to RK from Isfahan University of Medical Sciences, Isfahan, Iran. The authors thank Prof. Mahin Hashemipour and Ms Ghazaleh Fatemi for helping in the sample collection.

References

1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, et al. The metabolic syndrome. Endocr Rev 2008;29:777–822.10.1210/er.2008-0024Suche in Google Scholar

2. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629–36.10.1161/ATVBAHA.107.151092Suche in Google Scholar

3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469–80.10.1111/j.1464-5491.2006.01858.xSuche in Google Scholar

4. Verhagen SN, Wassink AM, van der Graaf Y, Gorter PM, Visseren FL, et al. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study. Cardiovasc Diabetol 2011;10:100.10.1186/1475-2840-10-100Suche in Google Scholar

5. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 1999;48:989–94.10.1016/S0026-0495(99)90195-6Suche in Google Scholar

6. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010;328:1566–9.10.1126/science.1189123Suche in Google Scholar PubMed PubMed Central

7. Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011;108:9232–7.10.1073/pnas.1102281108Suche in Google Scholar PubMed PubMed Central

8. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125–31.10.1172/JCI0215593Suche in Google Scholar

9. Harding AH, Loos RJ, Luan J, O’Rahilly S, Wareham NJ, et al. Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes. Diabetologia 2006;49:2642–8.10.1007/s00125-006-0430-1Suche in Google Scholar PubMed PubMed Central

10. Laudes M, Barroso I, Luan J, Soos MA, Yeo G, et al. Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes 2004;53:842–6.10.2337/diabetes.53.3.842Suche in Google Scholar PubMed

11. Eberle D, Clement K, Meyre D, Sahbatou M, Vaxillaire M, et al. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 2004;53:2153–7.10.2337/diabetes.53.8.2153Suche in Google Scholar

12. Felder TK, Oberkofler H, Weitgasser R, Mackevics V, Krempler F, et al. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int J Obes (Lond) 2007;31:1099–103.10.1038/sj.ijo.0803505Suche in Google Scholar

13. Liu JX, Liu J, Li PQ, Xie XD, Guo Q, et al. Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population. Diabetes Res Clin Pract 2008;82:42–7.10.1016/j.diabres.2008.06.017Suche in Google Scholar

14. Grarup N, Stender-Petersen KL, Andersson EA, Jorgensen T, Borch-Johnsen K, et al. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes 2008;57:1136–42.10.2337/db07-1534Suche in Google Scholar

15. Musso G, Bo S, Cassader M, De Michieli F, Gambino R. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. Am J Clin Nutr 2013;98:895–906.10.3945/ajcn.113.063792Suche in Google Scholar

16. Lu Y, Feskens EJ, Boer JM, Imholz S, Verschuren WM, et al. Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis 2010;213:200–5.10.1016/j.atherosclerosis.2010.08.053Suche in Google Scholar

17. Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, et al. Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr 2006;95:1625–34.10.1080/08035250600750072Suche in Google Scholar

18. Vedie B, Jeunemaitre X, Megnien JL, Atger V, Simon A, et al. A new DNA polymorphism in the 5’ untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population. Atherosclerosis 2001;154:589–97.10.1016/S0021-9150(00)00569-4Suche in Google Scholar

19. Liu JX, Liu J, Guo Q, Liu J. Association of sterol regulatory element binding protein-1c genetic polymorphisms rs2297508 and rs11868035 with type 2 diabetes mellitus in Gansu Han and Dongxiang population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2012;29:328–33.Suche in Google Scholar

20. Zhang Z, Gong RR, Du J, Xiao LY, Duan W, et al. Associations of the SREBP-1c gene polymorphism with gender-specific changes in serum lipids induced by a high-carbohydrate diet in healthy Chinese youth. Appl Physiol Nutr Metab 2011;36:226–32.10.1139/h11-005Suche in Google Scholar PubMed

Received: 2014-3-7
Accepted: 2014-4-1
Published Online: 2014-5-13
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Welcome to Assistant Editors at JPEM
  4. Review article
  5. Common approach to childhood obesity in Japan
  6. Images in pediatric endocrinology
  7. Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood
  8. Original articles
  9. Prevalence of vitamin D deficiency among Iranian adolescents
  10. Analysis of body composition among children and adolescents – a cross-sectional study of the Polish population and comparison of body fat measurement methods
  11. Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance
  12. Differences in anxiety and depression between male and female caregivers of children with a disorder of sex development
  13. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity
  14. The effect of growth hormone treatment on height in children with idiopathic short stature
  15. Clinical characteristics of type 1 diabetes over a 40 year period in Turkey: secular trend towards earlier age of onset
  16. Relationships of gamma-glutamyltransferase and beta 2-microglobulin on high sensitivity C-reactive protein among Japanese elementary school children
  17. Evaluation of insulin resistance and metabolic syndrome in a group of obese Czech children
  18. Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children
  19. Association between vitamin D level and cardiovascular risk in obese children and adolescents
  20. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents
  21. Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves’ disease compared with adolescent patients
  22. Influence of hormonal parameters, bone mineral density and bone turnover on fracture risk in healthy male adolescents: a case control study
  23. Evaluation of lipid and glucose metabolism and cortisol and thyroid hormone levels in obese appropriate for gestational age (AGA) born and non-obese small for gestational age (SGA) born prepubertal Slovak children
  24. Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children
  25. Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
  26. Gut hormone profiles in preterm and term infants during the first 2 months of life
  27. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review
  28. A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism
  29. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood
  30. Patient Reports
  31. Neonatal diabetes in an infant of diabetic mother: same novel INS missense mutation in the mother and her offspring
  32. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature
  33. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome
  34. Vitamin D intoxication in two brothers: be careful with dietary supplements
  35. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing
  36. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status
  37. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism
  38. An association of hypochondroplasia and immune deficiency
  39. Hypophosphatemic rickets caused by a novel PHEX gene mutation in an Indian girl
  40. Psoriasis vulgaris and autoimmune polyendocrine syndrome type I: a case report
  41. Identification of a combined missense/splice-site mutation in FAH causing tyrosinemia type 1
  42. Letter to the Editor
  43. Vitamin D intake and premature infants with intraventricular hemorrhage: how advisable is it?
Heruntergeladen am 20.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0115/pdf
Button zum nach oben scrollen